Trailing-twelve-month (TTM) revenue is $1.85 Billion with a year-over-year growth of +29.50%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2026Period ended 2025-11-01 | $415,975,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-12-09 |
| Q4 FY2026Period ended 2026-01-31 | $444,296,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-16 |
| Q1 FY2027Period ended 2026-05-02 | $478,844,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-09 |
| Q2 FY2027Period ended 2026-08-01 | $508,437,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-08 |
| TTM revenue | $1,847,552,000 |
Current P/S: $22,603,334,677 market capitalization ÷ $1,847,552,000 TTM revenue = 12.23x.
Market capitalization source: FMP quote. Quote observed 2026-09-23T19:55:16.000Z. Latest revenue period ended 2026-08-01.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2027 (2026-08-01): $508.44M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 19 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-23T19:55:48.157Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20232023-01-28 · USD | FY20242024-02-03 · USD | FY20252025-02-01 · USD | FY20262026-01-31 · USD |
|---|---|---|---|---|
| Product and Service, Other | $13M | $18M | $23M | $30M |
| Subscription and Circulation | $640M | $919M | $1.2B | $1.6B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20232023-01-28 · USD | FY20242024-02-03 · USD | FY20252025-02-01 · USD | FY20262026-01-31 · USD |
|---|---|---|---|---|
| Non-US | $71M | $116M | $167M | $233M |
| UNITED STATES | $582M | $822M | $1.1B | $1.4B |
$1.85B
$1.85 Billion
+29.50%
vs. $1.43B a year ago (TTM)
+45.31%
5 Year compound annual growth rate
1 Year
+29.50%
3 Year
+33.19%
5 Year
+45.31%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $1.62B | +$369.44M | +29.57% |
| 2025 | $1.25B | +$311.81M | +33.26% |
| 2024 | $937.38M | +$284.84M | +43.65% |
| 2023 | $652.54M | +$224.20M | +52.34% |
| 2022 | $428.35M | +$178.44M | +71.40% |
| 2021 |
TTM Growth
+29.50%
3-Year CAGR
+33.19%
5-Year CAGR
+45.31%
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-23T19:55:48.157Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $249.91M |
| +$130.04M |
| +108.49% |
